Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comEvaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer
Description:
The goal of this study is to evaluate the imaging capabilities of a new prostate-targeted PET system (P-PET) and determine whether it could be useful in detecting prostate cancer by comparing SOC whole body PET imaging. This pilot study will include adult men who have been diagnosed with or are suspected to have prostate cancer. Participants will undergo a standard-of-care PET/CT scan followed by an additional P-PET scan designed to provide detailed images of the prostate. The images from the two scans to assess how well the P-PET system can detect prostate cancer.
Sponsor:
Sunnybrook Health Sciences Centre
Phase:
N/A
Contacts:
Maureen Dougan (CONTACT)maureen.dougan@sjhc.london.on.ca
519-685-8300
Stephen Pautler, BSc MD FRCSC (PRINCIPAL_INVESTIGATOR)Government Study Link:
NCT07510906 - Click here to see study onClinicalTrials.gov
PSMA-1007
- PSMA
- Qualitative comparison of PET scans acquired by the P-PET vs. WB PET
- Unable to comply with the length of scan time due to the study imaging.
Share your feedback
Help us improve your experience